LBA33RANDOMIZED, DOUBLE-BLIND STUDY OF SONIDEGIB (LDE225) IN PATIENTS (PTS) WITH ADVANCED BASAL CELL CARCINOMA (BCC)

R. Dummer1, A. Guminski2, R. Gutzmer3, L. Dirix4, K. Lewis5, P. Combemale6, R. Herd7, M. Kaatz8, C. Loquai9, A. Stratigos10, H. Schulze11, R. Plummer12, T. Yi13, A.L.S. Chang14, F. Cornelis15, R. Kudchadkar16, U. Trefzer17, J. Lear18, D. Sellami19, M.R. Migden20 Department of Dermatology, UniversitatsSpital Zurich, Skin Cancer Center University Hospital, Zurich, SWITZERLAND Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, AUSTRALIA Department of Dermatology and Allergy, Skin Cancer Center, Medizinische Hochschule Hannover, Hannover, GERMANY Clinical Trials Oncology, Oncologisch Centrum Sint-Augustinus, Antwerp, BELGIUM Division of Medical Oncology, University of Colorado Cancer Center, Aurora, CO, USA Oncodermatology Unit, Centre Leon Berard, Lyon, FRANCE Department of Dermatology, Glasgow Royal Infirmary, Glasgow, UK Department of Dermatology and Allergology, University Hospital Jena, Freiburg, GERMANY Skin Cancer Center, Johannes Gutenberg-Universitat Mainz, Mainz, GERMANY Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, GREECE Department of Dermatology, Fachklinik Hornheide, Munster, GERMANY Northern Centre for Cancer Care, Freeman Hospital, Newcastle Upon Tyne, UK Biometrics & Data Management, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA Cancer Center, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, BELGIUM Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA Department of Dermatology, Allergology, and Tumor Therapy, Dermatologikum Berlin, Berlin, GERMANY Department of Dermatology, Manchester Royal Infirmary, Manchester, UK Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Departments of Dermatology and Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA